Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 4 · newest first

  1. Clinicopathological features and prognostic factors of pulmonary pleomorphic carcinomaCancer Treatment and Research Communications · 2026
  2. Immune checkpoint inhibitor (ICI) associated corneal allograft rejectionCancer Treatment and Research Communications · 2026
  3. Opium and opioid use and cancer risk: A systematic review and meta-analysis of epidemiological studiesCancer Treatment and Research Communications · 2026
  4. Prognostic impact of spread through air spaces (STAS) in mucin-producing lung adenocarcinoma: a multinational cohort studyCancer Treatment and Research Communications · 2026
  5. Engineering of ovine pancreatic RNase A as an Anti-tumor agent through in silico and experimental approachesCancer Treatment and Research Communications · 2026
  6. A comparative analysis of cytotoxic effects: Lactobacillus reuteri Extract vs. Newcastle Disease Virus in human colorectal cancer (HT-29 cell line)Cancer Treatment and Research Communications · 2026
  7. Recent advances in biomarkers, artificial intelligence, and targeted therapeutic strategies in breast cancer: Current progress and future perspectivesCancer Treatment and Research Communications · 2026
  8. Lymphatic extracellular vesicles and non-coding rnas in the melanoma sentinel lymph node pre-metastatic niche: Emerging lessons from aggressive skin cancersCancer Treatment and Research Communications · 2026
  9. Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironmentCancer Treatment and Research Communications · 2026
  10. Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancerCancer Treatment and Research Communications · 2026
  11. Fumarate hydratase-deficient renal cell carcinoma – results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatmentCancer Treatment and Research Communications · 2026
  12. Key target genes of miR-625-5p in colorectal cancer: uncovering novel therapeutic targets within regulatory networkCancer Treatment and Research Communications · 2026
  13. PPARγ activation sensitizes MSS gastrointestinal cancer cells to PD1 blockageCancer Treatment and Research Communications · 2026
  14. Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significanceCancer Treatment and Research Communications · 2026
  15. Molecular determinants of Bortezomib sensitivity and resistance in multiple myelomaCancer Treatment and Research Communications · 2026
  16. Role of circadian clock in oral squamous cell carcinoma pathogenesis and treatmentCancer Treatment and Research Communications · 2026
  17. Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHSCancer Treatment and Research Communications · 2026
  18. Performance status 2 or higher in EMA labels for advanced non-small-cell lung cancer: a cross-sectional SmPC analysisCancer Treatment and Research Communications · 2026
  19. Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B studyCancer Treatment and Research Communications · 2026
  20. Impact of the COVID-19 pandemic on cancer screening in Europe: A systematic review of disruptions, barriers, and policy responsesCancer Treatment and Research Communications · 2026
  21. Role of microRNA-451a in molecular pathology of cancerCancer Treatment and Research Communications · 2026
  22. The association of glucose disposal rate on cancer odds mediated by composite inflammatory biomarkers: a cross-sectional studyCancer Treatment and Research Communications · 2026
  23. Long-term results of postoperative whole-breast irradiation plus simultaneous integrated boost (SIB) for adolescents and young adults (AYA) diagnosed with early breast cancer after undergoing breast-conserving surgery in a single instituteCancer Treatment and Research Communications · 2026
  24. Curcumin as a natural photosensitizer in photodynamic therapy: efficacy against metastatic melanoma cellsCancer Treatment and Research Communications · 2026
  25. Altered expression of ET-1 and HMGB1 together with higher MMP-9 activity in serum-derived exosomes of chronic lymphocytic leukemiaCancer Treatment and Research Communications · 2026
  26. Beyond the clinical trial: Real-world treatment patterns and drivers of PD-(L)1 therapy use in first-line metastatic NSCLCCancer Treatment and Research Communications · 2026
  27. Expression of PCAT19, miR-195, ITGA6, and E-cadherin in prostate cancer: a preliminary tissue-based studyCancer Treatment and Research Communications · 2026
  28. Gut microbiota regulating programmed cell death: Impacts on cancer immunotherapy, mechanisms, therapeutic responses and intervention strategiesCancer Treatment and Research Communications · 2026
  29. Efficacy and safety of first-line EGFR-TKI combined with chemotherapy versus EGFR-TKI monotherapy in patients with EGFR-mutant non-small cell lung cancer and liver metastases: A propensity score–matched analysisCancer Treatment and Research Communications · 2026
  30. Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studiesCancer Treatment and Research Communications · 2026
  31. Pertuzumab–Docetaxel–Trastuzumab regimen in HER2-positive metastatic breast cancer: Real-world data from IndiaCancer Treatment and Research Communications · 2026
  32. The association between greenness, walkability, and post-menopausal breast cancer risk in Alberta’s Tomorrow ProjectCancer Treatment and Research Communications · 2026
  33. Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG studyCancer Treatment and Research Communications · 2026
  34. Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysisCancer Treatment and Research Communications · 2026
  35. CRISPR-Cas9 gene editing approaches in colorectal cancer: Current progress and future prospectsCancer Treatment and Research Communications · 2026
  36. Epidemiological and pathological profile of gastric cancer: A 10-year cross-sectional study in Khorramabad, Western IranCancer Treatment and Research Communications · 2026
  37. Characterizing symptom patterns in early-onset colorectal cancer: insights from a national inpatient analysisCancer Treatment and Research Communications · 2026
  38. Synergistic regulation of tumor angiogenesis via flavonoid modulation of lncRNAs: Mechanistic insights and therapeutic potentialCancer Treatment and Research Communications · 2026
  39. Association of apolipoprotein A2 isoform index with demographic, behavioral, and clinical risk factors for pancreatic ductal adenocarcinoma in a single-center observational study: considerations for development of a pancreatic cancer screening algorithm?Cancer Treatment and Research Communications · 2026
  40. Mapping the mutational terrain of lung adenocarcinoma: A Danish cohort study of 880 patientsCancer Treatment and Research Communications · 2026
  41. Comparison of regorafenib and immunotherapy in colorectal cancer survival: A multicenter cohort studyCancer Treatment and Research Communications · 2026
  42. Diagnostic performance of pap smear for cervical intraepithelial neoplasia in women with treatment-resistant vaginal infections: A colposcopy-guided biopsy correlated studyCancer Treatment and Research Communications · 2026
  43. Application of landmark analysis and piecewise Cox regression to identify features associated with prognosis: A national retrospective cohort study of New Zealand womenCancer Treatment and Research Communications · 2026
  44. Conversion treatment with hepatic arterial infusion of oxaliplatin, leucovorin and fluorouracil plus intravenous bevacizumab or cetuximab for initially unresectable colorectal liver metastasis: A prospective studyCancer Treatment and Research Communications · 2026
  45. Traditional Chinese medicine-mediated ferroptosis in cancer therapy: mechanisms, advances, and nanotechnology-driven delivery strategiesCancer Treatment and Research Communications · 2026
  46. Characterization of POU2F3-expressing large cell neuroendocrine carcinoma of the lung: A comprehensive analysis of morphology, immunohistochemistry, and genomic alterationsCancer Treatment and Research Communications · 2026
  47. Non-Coding RNAs in breast cancer bone metastasis: Regulators and novel therapeutic targetsCancer Treatment and Research Communications · 2026
  48. Role of non-animal 3D models in H. pylori associated gastric carcinogenesis: Insights and future perspectivesCancer Treatment and Research Communications · 2026
  49. OTUB1/SLC7A11 axis promoted AKT signaling activation to mediate ovarian cancer progressionCancer Treatment and Research Communications · 2026
  50. Beyond hyponatremia: serum sodium below 137 mEq/L and postoperative sodium trajectory as prognostic markers in resected non-small cell lung cancerCancer Treatment and Research Communications · 2026